Filing Details

Accession Number:
0001415889-21-003256
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-29 17:25:28
Reporting Period:
2021-06-28
Accepted Time:
2021-06-29 17:25:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1479419 Kala Pharmaceuticals Inc. KALA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1415537 T Mark Iwicki C/O Kala Pharmaceuticals, Inc.
490 Arsenal Way, Suite 120
Watertown MA 02472
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-28 7,586 $5.77 296,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
  2. Includes 279,080 unvested RSUs.